
501 - 1000 employees
Founded 1992
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $10M Debt on 2020-04
Biotechnology • Pharmaceuticals • Healthcare
Dendreon is a biotechnology company focused on developing and delivering cellular immunotherapies. Dendreon developed PROVENGE (sipuleucel‑T), the first FDA‑approved cellular immunotherapy, which has been administered to nearly 40,000 men, and the company provides research, development, and end-to-end cellular therapy manufacturing and logistics services to advance complex cell therapies and enable partners to bring treatments to market.
📡 We watch Dendreon's careers page
Every 2 hours
how often we check
2
roles posted in the last 30 days
Selected: 🆕 Date Added.
🔥 1 minute ago
Key Account Manager driving account growth and patient access for Dendreon’s personalized prostate-cancer immunotherapy. Managing urology and oncology partnerships across Upstate New York.
🗽 New York – Remote
💰 $10M Debt on 2020-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
💰 Account Manager
👻 Ghost score 15%
🔥 1 minute ago
Field Reimbursement Manager removing coverage, coding, and reimbursement barriers for Dendreon’s PROVENGE cancer immunotherapy. Partnering with U.S. healthcare providers and payors across multiple regions.
🇺🇸 United States – Remote
💰 $10M Debt on 2020-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager
👻 Ghost score 15%